Chickenpox Vaccine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Vaccine ( Monovalent Varicella Vaccine, Combination Varicella Vaccine ); Application ( Kids Injection, Adults Injection )

Report Code: TIPRE00019627 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Chickenpox vaccines enclosed an attenuated (weakened) live strain of the varicella-zoster (chickenpox) virus. Serious diseases such as herpes zoster and chickenpox can be caused as these vaccines stimulate the immune system against the varicella-zoster virus. Varicella vaccines are of two types namely monovalent and combination varicella vaccines. Absence of chickenpox immunization can lead to complications such as bacterial infections of the skin, joints or bloodstream (sepsis), soft tissues, bones, pneumonia, encephalitis, or even cause death.

MARKET DYNAMICS

Active contribution of government in immunization programs, growing awareness on the subject of chickenpox vaccines usage, and surge in the recognition of chickenpox vaccines are the key driving factors in chickenpox vaccine market. For instance, as per the Centers for Disease Control and Prevention (CDC), in United States each year about 11,000 individuals are hospitalized due to chicken pox complications. However, time required for the development of this vaccine and high cost associated with it is limiting the usage of chickenpox vaccine.

MARKET SCOPE

The "Chickenpox Vaccine Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of chickenpox vaccine market with detailed market segmentation by vaccine and application. The chickenpox vaccine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in chickenpox vaccine market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The chickenpox vaccine market is segmented on the basis of vaccine and application. Based on vaccine, the market is segmented as monovalent varicella vaccine and combination varicella vaccine. By application, kids injection and adults injection is the segmentation.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the chickenpox vaccine market based onvarious segments.It also provides market size and forecast estimates from year 2020 to2028with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The chickenpox vaccine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting chickenpox vaccine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the chickenpox vaccine market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the chickenpox vaccine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from chickenpox vaccine market are anticipated to have lucrative growth opportunities in the future with the rising demand for chickenpox vaccine in the global market. Below mentioned is the list of few companies engaged in the chickenpox vaccine market.

The report also includes the profiles of key players in chickenpox vaccine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and vaccine and applications offered, financial information of last 3 years, key development in past five years.

  •  GLAXOSMITHKLINE PLC
  •  MERCK AND CO. INC.
  •  GC PHARMA (GREEN CROSS HOLDINGS)
  •  BIO-MED PVT LTD
  •  NOVO MEDI SCIENCES PVT LTD
  •  SANOFI
  •  TAKEDA PHARMACEUTICAL COMPANY LIMITED
  •  MITSUBISHI TANABE PHARMA CORPORATION
  •  BIKEN
  •  KEYGEN

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Chickenpox Vaccine Market - By Vaccine
1.3.2 Chickenpox Vaccine Market - By Application
1.3.3 Chickenpox Vaccine Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CHICKENPOX VACCINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CHICKENPOX VACCINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CHICKENPOX VACCINE MARKET - GLOBAL MARKET ANALYSIS
6.1. CHICKENPOX VACCINE - GLOBAL MARKET OVERVIEW
6.2. CHICKENPOX VACCINE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. CHICKENPOX VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - VACCINE
7.1. OVERVIEW
7.2. VACCINE MARKET FORECASTS AND ANALYSIS
7.3. MONOVALENT VARICELLA VACCINE
7.3.1. Overview
7.3.2. Monovalent Varicella Vaccine Market Forecast and Analysis
7.4. COMBINATION VARICELLA VACCINE
7.4.1. Overview
7.4.2. Combination Varicella Vaccine Market Forecast and Analysis
8. CHICKENPOX VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. KIDS INJECTION
8.3.1. Overview
8.3.2. Kids Injection Market Forecast and Analysis
8.4. ADULTS INJECTION
8.4.1. Overview
8.4.2. Adults Injection Market Forecast and Analysis
9. CHICKENPOX VACCINE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Chickenpox Vaccine Market Overview
9.1.2 North America Chickenpox Vaccine Market Forecasts and Analysis
9.1.3 North America Chickenpox Vaccine Market Forecasts and Analysis - By Vaccine
9.1.4 North America Chickenpox Vaccine Market Forecasts and Analysis - By Application
9.1.5 North America Chickenpox Vaccine Market Forecasts and Analysis - By Countries
9.1.5.1 United States Chickenpox Vaccine Market
9.1.5.1.1 United States Chickenpox Vaccine Market by Vaccine
9.1.5.1.2 United States Chickenpox Vaccine Market by Application
9.1.5.2 Canada Chickenpox Vaccine Market
9.1.5.2.1 Canada Chickenpox Vaccine Market by Vaccine
9.1.5.2.2 Canada Chickenpox Vaccine Market by Application
9.1.5.3 Mexico Chickenpox Vaccine Market
9.1.5.3.1 Mexico Chickenpox Vaccine Market by Vaccine
9.1.5.3.2 Mexico Chickenpox Vaccine Market by Application
9.2. EUROPE
9.2.1 Europe Chickenpox Vaccine Market Overview
9.2.2 Europe Chickenpox Vaccine Market Forecasts and Analysis
9.2.3 Europe Chickenpox Vaccine Market Forecasts and Analysis - By Vaccine
9.2.4 Europe Chickenpox Vaccine Market Forecasts and Analysis - By Application
9.2.5 Europe Chickenpox Vaccine Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Chickenpox Vaccine Market
9.2.5.1.1 Germany Chickenpox Vaccine Market by Vaccine
9.2.5.1.2 Germany Chickenpox Vaccine Market by Application
9.2.5.2 France Chickenpox Vaccine Market
9.2.5.2.1 France Chickenpox Vaccine Market by Vaccine
9.2.5.2.2 France Chickenpox Vaccine Market by Application
9.2.5.3 Italy Chickenpox Vaccine Market
9.2.5.3.1 Italy Chickenpox Vaccine Market by Vaccine
9.2.5.3.2 Italy Chickenpox Vaccine Market by Application
9.2.5.4 Spain Chickenpox Vaccine Market
9.2.5.4.1 Spain Chickenpox Vaccine Market by Vaccine
9.2.5.4.2 Spain Chickenpox Vaccine Market by Application
9.2.5.5 United Kingdom Chickenpox Vaccine Market
9.2.5.5.1 United Kingdom Chickenpox Vaccine Market by Vaccine
9.2.5.5.2 United Kingdom Chickenpox Vaccine Market by Application
9.2.5.6 Rest of Europe Chickenpox Vaccine Market
9.2.5.6.1 Rest of Europe Chickenpox Vaccine Market by Vaccine
9.2.5.6.2 Rest of Europe Chickenpox Vaccine Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Chickenpox Vaccine Market Overview
9.3.2 Asia-Pacific Chickenpox Vaccine Market Forecasts and Analysis
9.3.3 Asia-Pacific Chickenpox Vaccine Market Forecasts and Analysis - By Vaccine
9.3.4 Asia-Pacific Chickenpox Vaccine Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Chickenpox Vaccine Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Chickenpox Vaccine Market
9.3.5.1.1 Australia Chickenpox Vaccine Market by Vaccine
9.3.5.1.2 Australia Chickenpox Vaccine Market by Application
9.3.5.2 China Chickenpox Vaccine Market
9.3.5.2.1 China Chickenpox Vaccine Market by Vaccine
9.3.5.2.2 China Chickenpox Vaccine Market by Application
9.3.5.3 India Chickenpox Vaccine Market
9.3.5.3.1 India Chickenpox Vaccine Market by Vaccine
9.3.5.3.2 India Chickenpox Vaccine Market by Application
9.3.5.4 Japan Chickenpox Vaccine Market
9.3.5.4.1 Japan Chickenpox Vaccine Market by Vaccine
9.3.5.4.2 Japan Chickenpox Vaccine Market by Application
9.3.5.5 South Korea Chickenpox Vaccine Market
9.3.5.5.1 South Korea Chickenpox Vaccine Market by Vaccine
9.3.5.5.2 South Korea Chickenpox Vaccine Market by Application
9.3.5.6 Rest of Asia-Pacific Chickenpox Vaccine Market
9.3.5.6.1 Rest of Asia-Pacific Chickenpox Vaccine Market by Vaccine
9.3.5.6.2 Rest of Asia-Pacific Chickenpox Vaccine Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Chickenpox Vaccine Market Overview
9.4.2 Middle East and Africa Chickenpox Vaccine Market Forecasts and Analysis
9.4.3 Middle East and Africa Chickenpox Vaccine Market Forecasts and Analysis - By Vaccine
9.4.4 Middle East and Africa Chickenpox Vaccine Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Chickenpox Vaccine Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Chickenpox Vaccine Market
9.4.5.1.1 South Africa Chickenpox Vaccine Market by Vaccine
9.4.5.1.2 South Africa Chickenpox Vaccine Market by Application
9.4.5.2 Saudi Arabia Chickenpox Vaccine Market
9.4.5.2.1 Saudi Arabia Chickenpox Vaccine Market by Vaccine
9.4.5.2.2 Saudi Arabia Chickenpox Vaccine Market by Application
9.4.5.3 U.A.E Chickenpox Vaccine Market
9.4.5.3.1 U.A.E Chickenpox Vaccine Market by Vaccine
9.4.5.3.2 U.A.E Chickenpox Vaccine Market by Application
9.4.5.4 Rest of Middle East and Africa Chickenpox Vaccine Market
9.4.5.4.1 Rest of Middle East and Africa Chickenpox Vaccine Market by Vaccine
9.4.5.4.2 Rest of Middle East and Africa Chickenpox Vaccine Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Chickenpox Vaccine Market Overview
9.5.2 South and Central America Chickenpox Vaccine Market Forecasts and Analysis
9.5.3 South and Central America Chickenpox Vaccine Market Forecasts and Analysis - By Vaccine
9.5.4 South and Central America Chickenpox Vaccine Market Forecasts and Analysis - By Application
9.5.5 South and Central America Chickenpox Vaccine Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Chickenpox Vaccine Market
9.5.5.1.1 Brazil Chickenpox Vaccine Market by Vaccine
9.5.5.1.2 Brazil Chickenpox Vaccine Market by Application
9.5.5.2 Argentina Chickenpox Vaccine Market
9.5.5.2.1 Argentina Chickenpox Vaccine Market by Vaccine
9.5.5.2.2 Argentina Chickenpox Vaccine Market by Application
9.5.5.3 Rest of South and Central America Chickenpox Vaccine Market
9.5.5.3.1 Rest of South and Central America Chickenpox Vaccine Market by Vaccine
9.5.5.3.2 Rest of South and Central America Chickenpox Vaccine Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CHICKENPOX VACCINE MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CHICKENPOX VACCINE MARKET, KEY COMPANY PROFILES
12.1. GLAXOSMITHKLINE PLC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. MERCK AND CO. INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GC PHARMA (GREEN CROSS HOLDINGS)
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BIO-MED PVT LTD
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. NOVO MEDI SCIENCES PVT LTD
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. SANOFI
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. TAKEDA PHARMACEUTICAL COMPANY LIMITED
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MITSUBISHI TANABE PHARMA CORPORATION
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. BIKEN
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. KEYGEN
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. GLAXOSMITHKLINE PLC
2. MERCK AND CO. INC.
3. GC PHARMA (GREEN CROSS HOLDINGS)
4. BIO-MED PVT LTD
5. NOVO MEDI SCIENCES PVT LTD
6. SANOFI
7. TAKEDA PHARMACEUTICAL COMPANY LIMITED
8. MITSUBISHI TANABE PHARMA CORPORATION
9. BIKEN
10. KEYGEN
TIPRE00019627
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking